Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units

NCT02213796 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Initial Phase of Severe Sepsis and Septic Shock

Interventions

DRUG: Meropenem

Sponsor

Sutep Jaruratanasirikul

Collaborators

[object Object]